Ad is loading...
MENU
SNDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Syndax Pharmaceuticals (SNDX) Ownership - Who owns Syndax Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.37B
P/E Ratio
N/A
Total Cash
406.4M
Projected Growth
N/A
Total Debt
854K
Revenue
16M
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash/Share
4.76
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
Fundamentals
SNDX
Capitalization
1.37B
P/E Ratio
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash
406M
Total Cash/Share
4.76
Total Debt
854K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
16M
ROE
N/A
Book Value
366M
P/B Ratio
3.75
Cash Flow
N/A
Earnings
-3.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
6.99
Current Revenue Per Employee
67934.78
Dividends Per Share - Security
N/A
EBITDA
-296.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-72.01
Shares Held By Institutions
3.76B
Shares Outstanding - Current
85.4M
Total Liabilities
59.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-25.544
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals for novel cancer therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com